Allogeneic Hematopoietic Cell Transplantation in Patients With Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria Clones: Time for a Change
Authors:
Open Access
- 1 April 2020
- journal article
- letter
- Published by Wiley in HemaSphere
- Vol. 4 (2) , e345
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Post-Allogeneic Hematopoietic Stem Cell Transplantation Eculizumab as Prophylaxis Against Hemolysis and Thrombosis for Patients with Hematologic Disorders Associated with Paroxysmal Nocturnal Hemoglobinuria ClonesTransplantation and Cellular Therapy, 2019
- Eculizumab Bridging before Bone Marrow Transplant for Marrow Failure Disorders Is Safe and Does Not Limit EngraftmentTransplantation and Cellular Therapy, 2018
- Renal involvement in paroxysmal nocturnal hemoglobinuria: an update on clinical features, pathophysiology and treatmentHematology, 2018
- Hematopoietic stem cell transplantation for patients with paroxysmal nocturnal hemoglobinuria previously treated with eculizumab: a retrospective study of 21 patients from SFGM-TC centersHaematologica, 2017
- How I treat acquired aplastic anemiaBlood, 2017
- Survival Advantage and Comparable Toxicity in Reduced-Toxicity Treosulfan-Based versus Reduced-Intensity Busulfan-Based Conditioning Regimen in Myelodysplastic Syndrome and Acute Myeloid Leukemia Patients after Allogeneic Hematopoietic Cell TransplantationTransplantation and Cellular Therapy, 2017
- Current outcome of HLA identical sibling versus unrelated donor transplants in severe aplastic anemia: an EBMT analysisHaematologica, 2015
- Investigation of the freely available easy-to-use software ‘EZR’ for medical statisticsBone Marrow Transplantation, 2012
- Aplastic Anemia: Pathophysiology and TreatmentTransplantation and Cellular Therapy, 2010
- Improved Detection and Characterization of Paroxysmal Nocturnal Hemoglobinuria Using Fluorescent AerolysinAmerican Journal of Clinical Pathology, 2000